Straumann Holding Ag · SIX:STMN
Straumann — Q1 2025 Earnings Presentation
23 slides from Straumann's earnings presentation, May 1, 2025
Slide 1: First Quarter Results 2025
2025 FIRST QUARTER RESULTS Presentation for investors, analysts and media Basel, April 30, 2025
Slide 2: Disclaimer
DISCLAIMER This presentation contains forward-looking statements, including statements regarding the beliefs, expectations and assumptions of future results, performance or achievements of Straumann Group, that are based upon information available to Straumann Group as of the date such statements ar
Slide 3: Agenda
AGENDA Highlights Guillaume Daniellot Financials Yang Xu Recent achievements & strategy Guillaume Daniellot Outlook 2025 Guillaume Daniellot Q&A Guillaume Daniellot, Yang Xu 3
Slide 4: Highlights
HIGHLIGHTS Guillaume Daniellot, CEO 4
Slide 5: Strong start into 2025
STRONG START INTO 2025 First quarter revenue in CHF1 Organic revenue growth1,2 Regional performance 681 m 11.0% EMEA & APAC Dynamic demand in most of our business Continued variation in regional market Growth across all businesses segments dynamics International Dental Show (IDS) Customer centricity
Slide 6: Strong start in an environment marked by macroeconomic uncertainties
STRONG START IN AN ENVIRONMENT MARKED BY MACROECONOMIC UNCERTAINTIES EMEA NAM Q1 10.0% Q1 24 9.2% Q1 1.8% Q1 24 3.7% 41 %* 27 %* GROUP APAC Q1 25 11.0% 8 %* 24 %* Q1 23.0% Q1 24 17.5% LATAM Q1 24 82.0% Q1 18.8% Q1 24 11.5% 6 * % of Q1 2025 Group total revenue
Slide 7: Financials
FINANCIALS Yang Xu, CFO 7
Slide 8: Strong results with varied regional dynamics
STRONG RESULTS WITH VARIED REGIONAL DYNAMICS REVENUE DEVELOPMENT BREAKDOWN IN CHF MILLION, ROUNDED +10.1% Regional % share of +11.0% organic growth Organic 9 681 5 NAM 30 12 LATAM 3 26 38 EMEA 618 0 613 -5 Change in organic growth 45 APAC +10.0% +1.8% +23.0% +18.8% Revenue FX effect M&A effect Adjus
Slide 9: Continued capital allocation principles
CONTINUED CAPITAL ALLOCATION PRINCIPLES FOCUS ON GROWTH INVESTMENT In priority order 1 Reinvest in sustainable business growth 2 Maintain strong balance sheet 3 Pursue M&A to accelerate strategy 4 Maintain and increase dividend with earnings growth 9
Slide 10: Recent achievements & strategy
RECENT ACHIEVEMENTS & STRATEGY Guillaume Daniellot, CEO 10
Slide 11: Huge opportunities in implantology and beyond
HUGE OPPORTUNITIES – IN IMPLANTOLOGY AND BEYOND ADDRESSABLE MARKET GREW FROM CHF 19 BN TO ABOUT CHF 20BN GLOBALLY 6 5.6 4.7 NEW Market size CUSTOMER in CHF bn 2.6 ACQUISITION THROUGH Market share % 35% 35% 0.7 ~15% ~3% >5% <5% INNOVATION Implantology Regeneratives ClearAligner CADCAM CADCAM equipmen
Slide 12: Massive growth potential due to low implant penetration
MASSIVE GROWTH POTENTIAL DUE TO LOW IMPLANT PENETRATION 900 2024 implant penetration per 10K adult population1 800 HUGE 700 600 500 benchmark MARKET 400 OPPORTUNITY AHEAD 300 200 100 VBP - South Korea Spain France Germany Brazil USA China UK + Ireland India Market opportunity Current penetration 12
Slide 13: Portfolio diversification allows to adapt to different market environment
PORTFOLIO DIVERSIFICATION ALLOWS TO ADAPT TO DIFFERENT MARKET ENVIRONMENT MULTI-PRICING STRATEGY Premium Digital DIVERSIFIED Challenger PORTFOLIO Ortho Premium 2013 2024 Challenger EMEA INCREASED NAM GLOBAL APAC Eco-Challenger FOOTPRINT LATAM 2013 2024 13 Source: Straumann Group estimates in value (
Slide 14: Well positioned supply chain to support customers
WELL POSITIONED SUPPLY CHAIN TO SUPPORT CUSTOMERS 19 PRODUCTION 19 SITES WORLDWIDE Headquarters Production site Served by subsidiary Served by distributor 14 including Shanghai campus which is not yet fully operational
Slide 15: Clear and consistent strategic roadmap
CLEAR AND CONSISTENT STRATEGIC ROADMAP THREE PILLARS TO CREATE ADDITIONAL CUSTOMER VALUE Innovation Digitalization Education 15
Slide 16: Innovation for best-in-class customer experience
INNOVATION FOR BEST-IN-CLASS CUSTOMER EXPERIENCE “WHAT” “HOW” Product innovation Digital innovation providing providing superior clinical excellence & superior clinician clinical evidence experience & practice efficiency 16
Slide 17: The future of dentistry and technology at IDS
THE FUTURE OF DENTISTRY AND TECHNOLOGY AT IDS CREATING VALUE AND EFFICIENCY FOR CLINICIANS Straumann SIRIOS Straumann Signature Midas Straumann Falcon iEXCEL BLC TLC BLX TLX 17
Slide 18: Straumann and SprintRay collaborate to drive unique chairside workflow with 3D printing
STRAUMANN AND SPRINTRAY COLLABORATE TO DRIVE UNIQUE CHAIRSIDE WORKFLOW WITH 3D PRINTING Unique chairside workflow with integration into the digital AXS platform – all in a single visit Straumann SIRIOS Straumann Signature Midas 18
Slide 19: Investments as key driver for growth
INVESTMENTS AS KEY DRIVER FOR GROWTH SHANGHAI CAMPUS FINALIZED AND 3RD FACTORY IN BRAZIL UNDERWAY Shanghai Campus Shanghai Campus Straumann 19
Slide 20: Outlook 2025: Confirmed
OUTLOOK 2025: CONFIRMED BARRING UNFORESEEN CIRCUMSTANCES Market environment and assumption Revenue and profitability • Macroeconomic uncertainty increases • Organic revenue growth in the high single-digit percentage range • Group’s global diversified portfolio expected to continue outgrowing the mar
Slide 21: Thank you, any questions?
THANK YOU ANY QUESTIONS? 21
Slide 22: Calendar of upcoming events
CALENDAR OF UPCOMING EVENTS 2025 Event Location 6 - 7 May Berenberg Roadshow London 8 – 9 May Kepler Cheuvreux Roadshow Amsterdam 12 May Bernstein Roadshow Madrid 13 May BofA Global Healthcare Conference Las Vegas 20 May Equita Roadshow Dublin 28 – 29 May Stifel Jaws and Paws Conference New York 4 –
Slide 23: Thank you
OU THANK Y » ae,